1. Home
  2. UNB vs ADVM Comparison

UNB vs ADVM Comparison

Compare UNB & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNB
  • ADVM
  • Stock Information
  • Founded
  • UNB 1891
  • ADVM 2006
  • Country
  • UNB United States
  • ADVM United States
  • Employees
  • UNB N/A
  • ADVM N/A
  • Industry
  • UNB Major Banks
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UNB Finance
  • ADVM Health Care
  • Exchange
  • UNB Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • UNB 117.7M
  • ADVM 94.6M
  • IPO Year
  • UNB 1998
  • ADVM 2014
  • Fundamental
  • Price
  • UNB $22.98
  • ADVM $4.32
  • Analyst Decision
  • UNB
  • ADVM Buy
  • Analyst Count
  • UNB 0
  • ADVM 5
  • Target Price
  • UNB N/A
  • ADVM $16.60
  • AVG Volume (30 Days)
  • UNB 11.2K
  • ADVM 1.0M
  • Earning Date
  • UNB 01-16-2026
  • ADVM 11-07-2025
  • Dividend Yield
  • UNB 6.29%
  • ADVM N/A
  • EPS Growth
  • UNB N/A
  • ADVM N/A
  • EPS
  • UNB 2.01
  • ADVM N/A
  • Revenue
  • UNB $48,950,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • UNB N/A
  • ADVM $1,449.40
  • Revenue Next Year
  • UNB N/A
  • ADVM N/A
  • P/E Ratio
  • UNB $11.34
  • ADVM N/A
  • Revenue Growth
  • UNB 2.99
  • ADVM N/A
  • 52 Week Low
  • UNB $21.79
  • ADVM $1.78
  • 52 Week High
  • UNB $37.70
  • ADVM $8.18
  • Technical
  • Relative Strength Index (RSI)
  • UNB 36.46
  • ADVM 50.91
  • Support Level
  • UNB $21.90
  • ADVM $4.18
  • Resistance Level
  • UNB $25.46
  • ADVM $4.34
  • Average True Range (ATR)
  • UNB 0.63
  • ADVM 0.26
  • MACD
  • UNB -0.14
  • ADVM -0.05
  • Stochastic Oscillator
  • UNB 30.34
  • ADVM 40.96

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: